Inventor · disambiguated record
Yi Zang
Also filed as: ZANG YI
12 granted patents·5 pending applications·111 citations·filing 2008–2021
87Inventor score
Files withMERCK SHARP & DOHME6CHOLODY WIESLAW M2DUFFY JOSEPH L2SHANGHAI INST MATERIA MEDICA CAS2DOGWOOD PHARMACEUTICALS INC1
Top patents by PatentIndex Score
17 records- 0193US8129519B2Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofCHOLODY WIESLAW M·Filed 2008·Granted Mar 6, 2012·97 cites·6 claims
- 0290US11230543B2Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infectionsMERCK SHARP & DOHME·Filed 2020·Granted Jan 25, 2022·2 cites·20 claims
- 0384US11433055B2Chromane monobactam compounds for the treatment of bacterial infectionsMERCK SHARP & DOHME·Filed 2018·Granted Sep 6, 2022·2 cites·21 claims
- 0481US9353101B2Cyclic amine substituted heterocyclic CETP inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted May 31, 2016·3 cites·17 claims
- 0576US10239863B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Mar 26, 2019·1 cites·19 claims
- 0674US12240841B2FXR small molecule agonist and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Mar 4, 2025·1 cites·15 claims
- 0774US10081617B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Sep 25, 2018·2 cites·11 claims
- 0869US8742110B2Spiroxazolidinone compoundsDUFFY JOSEPH L·Filed 2011·Granted Jun 3, 2014·3 cites·15 claims
- 0958US2016257668A1Factor XIa InhibitorsSHAO NING·Filed 2014·Application pending·0 cites
- 1054US9120754B2Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofCHOLODY WIESLAW M·Filed 2012·Granted Sep 1, 2015·0 cites·19 claims
- 1154US2018339983A1Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infectionsMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 1251US9446021B2Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofDOGWOOD PHARMACEUTICALS INC·Filed 2015·Granted Sep 20, 2016·0 cites·15 claims
- 1349US2023357244A1Fxr small-molecule agonist, and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 1447US11730742B2Pharmaceutical use of thiophene [3,2-d] pyrimidine-4-ketone compoundSHANGHAI INST OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCE·Filed 2019·Granted Aug 22, 2023·0 cites·9 claims
- 1546US2016229839A1Factor XIa InhibitorsMERTZ ERIC·Filed 2014·Application pending·0 cites
- 1641US11655239B2Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereofSHANGHAI INSTITUTE OF MAT MEDICA CHINESE ACADEMY OF SCIENCES·Filed 2020·Granted May 23, 2023·0 cites·16 claims
- 1731US2013040978A1Spiro isoxazoline compounds as sstr5 antagonistsDUFFY JOSEPH L·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yi Zang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →